These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35432441)

  • 1. Construction of the Six-lncRNA Prognosis Signature as a Novel Biomarker in Esophageal Squamous Cell Carcinoma.
    Zheng ZJ; Li YS; Zhu JD; Zou HY; Fang WK; Cui YY; Xie JJ
    Front Genet; 2022; 13():839589. PubMed ID: 35432441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-coding genes combined with long non-coding RNAs predict prognosis in esophageal squamous cell carcinoma patients as a novel clinical multi-dimensional signature.
    Guo JC; Li CQ; Wang QY; Zhao JM; Ding JY; Li EM; Xu LY
    Mol Biosyst; 2016 Oct; 12(11):3467-3477. PubMed ID: 27714034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma.
    Zhang L; Li P; Liu E; Xing C; Zhu D; Zhang J; Wang W; Jiang G
    Cancer Cell Int; 2020; 20():386. PubMed ID: 32831646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Significance of Metabolic Syndrome and a Related Six-lncRNA Signature in Esophageal Squamous Cell Carcinoma.
    Liu Y; Wang L; Liu H; Li C; He J
    Front Oncol; 2020; 10():61. PubMed ID: 32133283
    [No Abstract]   [Full Text] [Related]  

  • 6. The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis.
    Weng NQ; Chi J; Wen J; Mai SJ; Zhang MY; Huang L; Liu J; Yang XZ; Xu GL; Fu JH; Wang HY
    J Transl Med; 2020 Jan; 18(1):47. PubMed ID: 32005248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
    Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
    Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A seven-lncRNA signature predicts overall survival in esophageal squamous cell carcinoma.
    Mao Y; Fu Z; Zhang Y; Dong L; Zhang Y; Zhang Q; Li X; Liu J
    Sci Rep; 2018 Jun; 8(1):8823. PubMed ID: 29891973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel immune-related radioresistant lncRNAs signature based model for risk stratification and prognosis prediction in esophageal squamous cell carcinoma.
    Zheng J; Chen X; Huang B; Li J
    Front Genet; 2022; 13():921902. PubMed ID: 36147506
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma.
    Wang P; Chen Y; Zheng Y; Fu Y; Ding Z
    Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
    BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of m
    Ma Y; Sun Y; Zhao X; Li J; Fu X; Gong T; Zhang X
    Sci Rep; 2023 Sep; 13(1):14499. PubMed ID: 37666951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative Analysis of Angiogenesis-Related Long Non-Coding RNA and Identification of a Six-DEARlncRNA Signature Associated with Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma.
    Cao S; Wang X; Liu X; Li J; Duan L; Gao Z; Lun S; Zhu Y; Yang H; Zhang H; Zhou F
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA Profiles Enable Prognosis Prediction and Subtyping for Esophageal Squamous Cell Carcinoma.
    Zhang S; Li J; Gao H; Tong Y; Li P; Wang Y; Du L; Wang C
    Front Cell Dev Biol; 2021; 9():656554. PubMed ID: 34127945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Clinical Six-Flavoprotein-Gene Signature Predicts Prognosis in Esophageal Squamous Cell Carcinoma.
    Peng L; Guo JC; Long L; Pan F; Zhao JM; Xu LY; Li EM
    Biomed Res Int; 2019; 2019():3869825. PubMed ID: 31815134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Serum Exosomal lncRNAs as Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma.
    Yan S; Du L; Jiang X; Duan W; Li J; Xie Y; Zhan Y; Zhang S; Wang L; Li S; Wang C
    Cancer Manag Res; 2020; 12():9753-9763. PubMed ID: 33116835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Autophagy-Related Long Non-Coding RNA Signature to Predict Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma.
    Shi X; Liu X; Pan S; Ke Y; Li Y; Guo W; Wang Y; Ruan Q; Zhang X; Ma H
    Int J Gen Med; 2021; 14():8325-8339. PubMed ID: 34815705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A more novel and robust gene signature predicts outcome in patients with esophageal squamous cell carcinoma.
    Ma C; Luo H
    Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102033. PubMed ID: 36265781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
    Li X; Xiao X; Chang R; Zhang C
    J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
    Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
    Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.